Investigation Overview
Company
Security
NASDAQ: VLRX
Summary
June 12, 2017 (Shareholders Foundation) - An investigation on behalf of investors in shares of Valeritas Holdings, Inc. (NASDAQ:VLRX) was announced over potential breaches of fiduciary duties by certain officers and directors at Valeritas Holdings.
The investigation by a law firm concerns whether certain Valeritas Holdings officers and directors breached their fiduciary duties.
Valeritas Holdings, Inc.is a commercial-stage medical technology company that is focused on developing technologies for Type 2 diabetes. Shares of Valeritas Holdings, Inc. (NASDAQ:VLRX) declined from $7.29 per share in April 2017 to $4.53 per share on June 5, 2017